Sujith Sarvesh

机构：UC San Diego Health System, University of Alabama at Birmingham, Maryland Oncology Hematology, University of California San Diego Medical Center · ORCID：0000-0002-2689-6568

发表论文 23 篇 · 总被引 132 次 · h-index 6

代表论文

• A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer (2024 · Cancer Research · 被引 25)
• Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions (2023 · Cytokine & Growth Factor Reviews · 被引 23)
• ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma (2025 · Molecular Cancer · 被引 22)
• Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine (2024 · Cell Reports Medicine · 被引 16)
• A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 13)
• Paricalcitol plus hydroxychloroquine enhances gemcitabine activity and induces mesenchymal to epithelial transition in pancreatic ductal adenocarcinoma: A single cell RNA-seq analysis (2025 · Cancer Letters · 被引 11)